STRIBILD

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Aug 27, 2012

   14 yr ago

2. Today

3. Patent 7176220 expires

   Listed drug substance patent expiration.

   Aug 27, 2026

   in 2 mo

4. Patent 7635704 expires

   Listed drug substance patent expiration.

   Oct 26, 2026

   in 4 mo

5. Patent 8981103 expires

   Listed drug substance patent expiration.

   Oct 26, 2026

   in 4 mo

6. Patent 7176220*PED expires

   Listed listed patent expiration.

   Feb 27, 2027

   in 8 mo

7. Patent 7635704*PED expires

   Listed listed patent expiration.

   Apr 26, 2027

   in 10 mo

8. Patent 8981103*PED expires

   Listed listed patent expiration.

   Apr 26, 2027

   in 10 mo

9. Patent 8148374 expires

   Listed drug substance patent expiration.

   Sep 03, 2029

   in 3 yr 3 mo

10. Patent 9891239 expires

    Listed drug product patent expiration.

    Sep 03, 2029

    in 3 yr 3 mo

11. Patent 8148374*PED expires

    Listed listed patent expiration.

    Mar 03, 2030

    in 3 yr 9 mo

12. Patent 9891239*PED expires

    Listed listed patent expiration.

    Mar 03, 2030

    in 3 yr 9 mo

13. Patent 8633219 expires

    Listed drug product patent expiration.

    Apr 30, 2030

    in 3 yr 11 mo

14. Patent 8633219*PED expires

    Listed listed patent expiration.

    Oct 30, 2030

    in 4 yr 5 mo

15. Patent 10039718 expires

    Listed drug product patent expiration.

    Oct 06, 2032

    in 6 yr 5 mo

16. Patent 10039718*PED expires

    Listed listed patent expiration.

    Apr 06, 2033

    in 6 yr 11 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (14)